|
CMIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
5.14379649985131E-11 |
| Normal-vs-Stage3 |
7.66053886991358E-15 |
| Normal-vs-Stage4 |
5.15059994654621E-09 |
| Stage1-vs-Stage2 |
7.925600E-01 |
| Stage1-vs-Stage3 |
4.290000E-01 |
| Stage1-vs-Stage4 |
8.989800E-01 |
| Stage2-vs-Stage3 |
7.714600E-01 |
| Stage2-vs-Stage4 |
9.454800E-01 |
| Stage3-vs-Stage4 |
7.316400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.03139999990876E-07 |
| Normal-vs-Asian |
3.84248188822767E-13 |
| Caucasian-vs-AfricanAmerican |
9.441200E-01 |
| Caucasian-vs-Asian |
1.615420E-01 |
| AfricanAmerican-vs-Asian |
4.214800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84563475613686E-12 |
| Normal-vs-Female |
1.72861724934137E-12 |
| Male-vs-Female |
3.094400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62980740014973E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.64213087572307E-12 |
| Normal-vs-Age(81-100Yrs) |
4.841900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.354000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.138400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.521800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.531600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.014600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.358200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.163800E-02 |
| Classical-VS-Follicular |
8.19090000000466E-05 |
| Classical-VS-Other |
3.832500E-02 |
| Classical-VS-Normal |
1.62503344114384E-12 |
| Tall-VS-Follicular |
7.197600E-01 |
| Tall-VS-Other |
2.439200E-01 |
| Tall-VS-Normal |
4.10300016184806E-10 |
| Follicular-VS-Other |
2.971400E-01 |
| Follicular-VS-Normal |
1.62925228863742E-12 |
| Other-VS-Normal |
9.59929999932996E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
6.69686528453894E-13 |
| N0-vs-N1 |
5.538600E-01 |
|
|
